Related Experiment Video
Updated: Feb 11, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
Calcium and Nuclear Signaling in Prostate Cancer
Ivan V Maly1, Wilma A Hofmann2
1Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, 955 Main Street, Buffalo, NY 14203, USA. ivanmaly@buffalo.edu.
Abstract:
Recently, there have been a number of developments in the fields of calcium and nuclear signaling that point to new avenues for a more effective diagnosis and treatment of prostate cancer. An example is the discovery of new classes of molecules involved in calcium-regulated nuclear import and nuclear calcium signaling, from the G protein-coupled receptor (GPCR) and myosin families. This review surveys the new state of the calcium and nuclear signaling fields with the aim of identifying the unifying themes that hold out promise in the context of the problems presented by prostate cancer. Genomic perturbations, kinase cascades, developmental pathways, and channels and transporters are covered, with an emphasis on nuclear transport and functions. Special attention is paid to the molecular mechanisms behind prostate cancer progression to the malignant forms and the unfavorable response to anti-androgen treatment. The survey leads to some new hypotheses that connect heretofore disparate results and may present a translational interest.
Insights
New insights into calcium and nuclear signaling offer novel diagnostic and treatment strategies for prostate cancer. Understanding molecular mechanisms driving cancer progression and treatment resistance is key.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Prostate cancer diagnosis and treatment face challenges, particularly in managing malignant progression and resistance to anti-androgen therapies.
- Recent advancements in understanding calcium and nuclear signaling pathways have revealed potential new therapeutic targets.
Purpose of the Study:
- To review current developments in calcium and nuclear signaling.
- To identify unifying themes relevant to prostate cancer diagnosis and treatment.
- To explore molecular mechanisms underlying prostate cancer progression and treatment resistance.
Main Methods:
- Literature review focusing on calcium signaling, nuclear import, and nuclear calcium signaling.
- Analysis of genomic perturbations, kinase cascades, developmental pathways, and channels/transporters.
- Emphasis on nuclear transport and functions in prostate cancer.
Main Results:
- Discovery of new molecular classes (GPCRs, myosin) involved in calcium-regulated nuclear processes.
- Identification of key pathways (genomic, kinase, developmental, transport) implicated in prostate cancer.
- Detailed examination of mechanisms driving malignant progression and anti-androgen treatment failure.
Conclusions:
- Unifying themes in calcium and nuclear signaling offer promising avenues for prostate cancer management.
- New hypotheses connecting disparate findings may lead to translational applications.
- Further research into these signaling pathways could improve diagnostic and therapeutic outcomes for prostate cancer.
Related Concept Videos
Nuclear Localization Signals and Import
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Nuclear Stability
To hold positively charged protons together...
Nuclear Fusion
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
Non-nuclear Inheritance
Nuclear Export of mRNA

